Posted inBriefs Compounding pharmacies can resume making tirzepatide as F.D.A. reconsiders shortage by Jeanne Pinder October 15, 2024October 15, 2024
Posted inCosts UnitedHealthcare’s Optum strongly criticized by psychologist, psychiatrist groups by Jeanne Pinder October 13, 2024March 29, 2025
Posted inCosts End of Mounjaro-Zepbound shortage may mean many people lose access to these medications by Jeanne Pinder October 10, 2024October 10, 2024
Posted inCosts Trade group sues F.D.A. over ending Mounjaro/Zepbound shortage by Jeanne Pinder October 9, 2024October 9, 2024
Posted inCosts ‘Nobody knows what these bills are for’: Americans shouldn’t have their credit ruined over a medical bill. by Jeanne Pinder October 7, 2024October 7, 2024
Posted inCosts G.A.O. wants C.M.S. to check whether hospitals’ price transparency data are actually usable by Jeanne Pinder October 4, 2024October 4, 2024
Posted inCosts You want us to pay our agreed-upon $300 for therapy? Nah, we’ll give you $200. by Jeanne Pinder September 27, 2024October 1, 2024
Posted inCosts ‘Making peoples’ lives hell’: When he couldn’t pay for cancer treatment, the hospital sued by Jeanne Pinder September 17, 2024September 17, 2024
Posted inCosts Do-it-yourself medicine draws frustrated patients to online forums by Jeanne Pinder September 16, 2024September 16, 2024
Posted inCosts Therapy can be a financial burden. Try telling your therapist that. by Jeanne Pinder September 15, 2024September 15, 2024
